SANDRA FORD: Open Payments
NPI 1447318357 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 23 payments from 10 companies in 2025. Trend: 2023 $192 · 2024 $480 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $244 |
| AstraZeneca Pharmaceuticals LP | 1 | $100 |
| Abbott Laboratories | 4 | $68 |
| Novo Nordisk Inc | 2 | $51 |
| Exact Sciences Corporation | 3 | $49 |
| PFIZER INC. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
Products named: ZEPBOUND, AIRSUPRA, FREESTYLE LIBRE 3, JARDIANCE, Ozempic, KISUNLA, Cologuard Collection Kit, REXULTI.
Industry payments across AL — which companies pay providers there.
